NASDAQ:VIRI
Delisted

Virios Therapeutics Stock Predictions

etoro logo Buy VIRI
*Your capital is at risk
$0.155
+0 (+0%)
At Close: Jan 07, 2025
Currently predicting for Mon, 8 Jun 2026

VIRI Prediction Chart

VIRI Predictions History

Latest community submissions for VIRI.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 17, 2023 $2.60 +7.44% $1.93 X 65.29% 0
Jul 7, 2023 $1.37 -5.18% $1.45 X 94.17% 0
Jul 7, 2023 $1.39 -3.24% $1.45 X 96.10% 0
Jul 7, 2023 $1.40 +7.69% $1.45 V 96.55% 1
Jul 5, 2023 $1.40 +2.94% $1.30 X 92.31% 0
Jul 3, 2023 $1.50 +8.70% $1.36 X 89.71% 0
Jul 3, 2023 $1.46 +5.73% $1.36 X 92.72% 0
Jul 3, 2023 $1.43 +3.58% $1.36 X 94.90% 0
Jeremy Marchand Jeremy Marchand @JeremyMarchand.208575
Jul 3, 2023 $1.50 +8.70% $1.36 X 89.71% 0
JS JS Pro
Jun 26, 2023 $1.32 -3.65% $1.56 X 84.62% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VIRI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIRIOS THERAPEUTICS, LLC
Virios Therapeutics
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, atten...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE